Join to View Full Profile
325 9th AveSeattle, WA 98104
Phone+1 206-543-4278
Are you Dr. Roxby?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alison Roxby, MD is an infectious disease specialist in Seattle, Washington. She is currently licensed to practice medicine in Washington and California. She is an Instructor at U of WA Sch of Med.
Education & Training
University of North Carolina at Chapel Hill School of MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2004 - Present
WA State Medical License 2006 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Brief Report: Associations Between Gender and Solicited Adverse Events After Passive Infusion of VRC01 or Placebo in HVTN 704/HPTN 085.Deborah A Theodore, Moni Neradilek, Kevin Gillespie, Srilatha Edupuganti, Juan Carlos Hinojosa
Journal of Acquired Immune Deficiency Syndromes. 2025-04-01 - Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people with...Tariro D Chawana, Stephen R Walsh, Lynda Stranix-Chibanda, Zvavahera M Chirenje, Chenchen Yu
BMC Immunology. 2025-02-19 - 1 citationsFactors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702.Rachel Chihana, Jia Jin Kee, Zoe Moodie, Yunda Huang, Holly Janes
Vaccine. 2024-08-13
Press Mentions
First Sex Activates Boost in Vaginal Immune Response, Study FindsOctober 28th, 2022- All Eyes on SeattleSeptember 8th, 2020
CDC Scientists Overruled in White House Push to Restart Airport Fever Screenings for COVID-19May 10th, 2020- Join now to see all
Grant Support
- Annual HVTN Translational HIV Early Stage Investigator (ESI) ConferenceFRED HUTCHINSON CANCER CENTER2017–2028
